You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The deal gives Oxford access to Imugen’s Lyme disease tests as well as PCR and immunoassay tests.
The firm expands its portfolio, providing customers with Dx for multiple applications
The test, which uses melt curve analysis and runs on a fully integrated platform from Zeesan, may have a head start on MDR and XDR tests from other companies.
Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.
In PLOS this week: founder mutation linked to some leukoencephalopathy cases, transcript and protein profiles of the kissing bug, and more.
A team in Spain used enhanced primer design, magnetic separation, and electrochemical detection to build a TB test as specific and sensitive as PCR.
The firm is using CMOS technology to develop a rapid TB test and other infectious disease panels, and is also partnering with other companies to enable tests.
In Nature this week: researchers uncover 13 healthy people who harbor Mendelian disease mutations, new tree of life, and more.
Researchers discussed using WGS to predict antibacterial resistance, to inform influenza vaccine development, and to diagnose and build drug resistance profiles for tuberculosis.
An international research team has mined tuberculosis whole-genome datasets to identify new mechanisms of resistance to highly toxic drugs.
A German shepherd called Nala has had her genome sequenced.
A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?
Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.
In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.